{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Delta Gold Technologies PLC (Aquis: DGQ /OTC: DGQTF) Accelerates Quantum Research Funding With University Of Toronto

April 9, 2026Delta Gold Technologies (Aquis: DGQ /OTC:DGQTF) announced it has advanced C$269,000 in Year 2 funding to the University of Toronto ahead of schedule to support quantum computing research focused on developing stable qubit building blocks using nano-scale gold and other materials, while also enabling early expansion of its cryo-refrigeration system; the funding is part of a broader C$3 million, three-year agreement securing Delta Gold a 100% exclusive global license to resulting intellectual property, as the company also moves to strengthen its leadership with the proposed appointment of James Tosh as Executive Director. To view the full press release, visit https://ibn.


TechMediaBreaks – Frontieras North America CEO Matthew T. McKean Highlights Breakthrough Technology, Market Momentum in Investor Webinar

April 9, 2026Webinar underscores Mason County progress, scalable FASForm platform and strong investor demand ahead of April 9 pricing change Frontieras North America CEO Matthew T. McKean, speaking during a recent investor webinar, highlighted the company’s accelerating momentum following its Mason County, West Virginia, groundbreaking while outlining the broader opportunity behind its FASForm technology.


Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value

April 9, 2026AINewsWire Editorial Coverage: Pharmaceutical manufacturing is entering a period of structural transformation as regulators impose increasingly stringent expectations around contamination control, data integrity and operational traceability. The European Union’s updated GMP Annex 1 guidance places strong emphasis on minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to evaluate and mitigate risks across personnel, processes and environments.


AINewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In Editorial On AI-Driven Transformation of Pharmaceutical Manufacturing

April 9, 2026Oncotelic Therapeutics (OTCQB: OTLC) is highlighted in an AINewsWire editorial examining the growing role of artificial intelligence in pharmaceutical manufacturing, where companies are integrating AI into workflows to enable continuous compliance with evolving GMP standards. The article notes that AI-powered systems are increasingly replacing manual, audit-based approaches with real-time monitoring and data-driven validation, positioning Oncotelic within a broader industry shift toward intelligent, automated production environments designed to enhance data integrity, reduce human error and improve operational efficiency.


AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Highlighted In Editorial On AI Robotics Driving Pharmaceutical Manufacturing Compliance

April 9, 2026Nightfood Holdings (OTCQB: NGTF), operating through TechForce Robotics, is featured in an AINewsWire editorial examining how artificial intelligence and robotics are transforming pharmaceutical manufacturing amid tightening regulatory requirements. The piece highlights the company’s development of AI-enabled robotic platforms with embedded SOP intelligence and real-time deviation detection, positioning it within a broader industry shift toward automation-driven compliance, reduced human intervention and improved data integrity as manufacturers respond to evolving GMP standards.


Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026 LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments The company recently strengthened its position through a strategic partnership with Liora Technologies and the expansion of clinical trials These developments highlight Lixte’s broader mission: To improve cancer outcomes through innovation, combination-based therapeutic strategies Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of its strategy.


Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value

April 9, 2026AINewsWire Editorial Coverage: Pharmaceutical manufacturing is entering a period of structural transformation as regulators impose increasingly stringent expectations around contamination control, data integrity and operational traceability. The European Union’s updated GMP Annex 1 guidance places strong emphasis on minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to evaluate and mitigate risks across personnel, processes and environments.


Porsche’s Patent Application Seeks to Retain Stick Shift in EVs

April 9, 2026Electric vehicles are steadily erasing the manual transmission from modern motoring, but Porsche appears unwilling to let it go without a fight. The German automaker filed a patent with its home country’s intellectual property office in mid-2024, with the application published earlier this year, outlining a concept designed to preserve the feel of a stick shift inside an electric car.


Japan Moves to Overhaul Crypto Regulatory System

April 9, 2026Japan is taking a major step to reshape how cryptocurrencies are regulated, signaling a shift toward treating digital assets as a core part of the financial system. This move reflects the country’s effort to keep up with the growing importance of crypto while protecting investors and ensuring market stability.


Pew Survey Highlights Shifting Views of Americans on Energy

April 9, 2026American views on energy are fracturing along partisan lines more sharply than at any point in recent memory, and a new Pew Research Center survey captures the depth of that divide. Conducted in March 2026 among roughly 3,500 adults, the poll landed during rising gas prices and market turbulence tied to the U.


Debate Rages on Viability of Proposed Copper Smelter in B.C.

April 9, 2026A proposed copper smelter and refinery on British Columbia’s West Coast is sparking divided opinions among industry experts, with some questioning its financial viability while others argue it could strengthen Canada’s position in the global copper market. The initiative, introduced late last year by federal and provincial governments, aims to move Canada further up the copper value chain and reduce dependence on overseas processing.